We are live on
!
Find out more
Luther King Capital Management (LKCM) Portfolio holdings
AUM
$24.4B
1-Year Est. Return
22.19%
This Fund
S&P 500
This Quarter
Est. Return
+5.26%
1 Year Est. Return
+22.19%
3 Year Est. Return
+74.81%
5 Year Est. Return
+96.49%
10 Year Est. Return
+450.05%
AUM
$13.7B
AUM Growth
+$630M
(+4.8%)
Cap. Flow
+$62.5M
Cap. Flow
% of AUM
0.46%
Top 10 Holdings %
Top 10 Hldgs %
24.09%
Holding
550
New
33
Increased
180
Reduced
167
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles River Laboratories
CRL
|
+$29.9M |
| 2 |
Air Products & Chemicals
APD
|
+$21.3M |
| 3 |
Oracle
ORCL
|
+$20.8M |
| 4 |
Corteva
CTVA
|
+$19.4M |
| 5 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$18.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.2M |
| 2 |
AbbVie
ABBV
|
+$39M |
| 3 |
DuPont de Nemours
DD
|
+$35.8M |
| 4 |
Emerson Electric
EMR
|
+$18.3M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
+$18.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.5% |
| 2 | Healthcare | 16.29% |
| 3 | Financials | 14.99% |
| 4 | Industrials | 13.61% |
| 5 | Consumer Discretionary | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Southwest Airlines
LUV
$22.4B
| $850K | 0.01% |
16,741
+3,106
| +23% | +$161K |
|
352
S&P Global
SPGI
$121B
| $837K | 0.01% |
+3,673
| New | +$802K |
|
353
Cerus
CERS
$516M
| $808K | 0.01% |
143,690
-49,955
| -26% | -$276K |
|
354
Phillips 66
PSX
$87.5B
| $793K | 0.01% |
8,479
+1,083
| +15% | +$97.2K |
|
355
Kroger
KR
$34.4B
| $790K | 0.01% |
36,400
-63
| -0.2% | -$1.53K |
|
356
Boston Scientific
BSX
$72.8B
| $786K | 0.01% |
18,296
-21,466
| -54% | -$826K |
|
|
GRMN
357
Garmin
GRMN
$60.1B
| $769K | 0.01% |
9,641
+205
| +2% | +$16.8K |
|
358
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
| – | – |
0
| – | – |
|
|
EXAS
359
DELISTED
Exact Sciences
EXAS
| $745K | 0.01% |
6,310
| – | – |
|
360
HEICO Corp
HEI
$51.3B
| $743K | 0.01% |
5,555
-3,580
| -39% | -$398K |
|
|
PCH
361
DELISTED
PotlatchDeltic
PCH
| $743K | 0.01% |
19,059
| – | – |
|
362
Gentex
GNTX
$5.09B
| $712K | 0.01% |
28,950
-3,450
| -11% | -$78.1K |
|
|
PFPT
363
DELISTED
Proofpoint, Inc.
PFPT
| $694K | 0.01% |
5,770
| – | – |
|
364
Novartis
NVS
$296B
| $670K | ﹤0.01% |
7,338
+3,102
| +73% | +$263K |
|
|
ZIXI
365
DELISTED
Zix Corporation
ZIXI
| $654K | ﹤0.01% |
72,000
-7,000
| -9% | -$60.9K |
|
|
MRSH
366
Marsh
MRSH
$90.6B
| $649K | ﹤0.01% |
6,510
| – | – |
|
|
BCOV
367
DELISTED
Brightcove, Inc.
BCOV
| $646K | ﹤0.01% |
62,500
+7,500
| +14% | +$72.3K |
|
368
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
| – | – |
0
| – | – |
|
369
Graco
GGG
$13.6B
| $628K | ﹤0.01% |
12,505
-6,110
| -33% | -$308K |
|
370
W.W. Grainger
GWW
$61.6B
| $626K | ﹤0.01% |
2,335
| – | – |
|
371
Gilead Sciences
GILD
$167B
| $620K | ﹤0.01% |
9,181
+660
| +8% | +$43.4K |
|
372
A10 Networks
ATEN
$2.01B
| $614K | ﹤0.01% |
90,000
+15,000
| +20% | +$98.3K |
|
373
Watsco Inc
WSO
$13.5B
| $606K | ﹤0.01% |
3,705
+1,515
| +69% | +$238K |
|
374
iShares MSCI Germany ETF
EWG
$1.68B
| – | – |
0
| – | – |
|
375
SEI Investments
SEIC
$12.6B
| $601K | ﹤0.01% |
10,708
-15,004
| -58% | -$809K |
|
Similar funds
SC
CS
JG
AF
Luther King Capital Management (LKCM)'s Q2 2019 Portfolio in Review
As of Q2 2019, Luther King Capital Management (LKCM) held 550 positions worth $13.7B, up 4.8% from $13.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Luther King Capital Management (LKCM)'s Q2 2019 filing shows 33 new, 180 increased, 167 reduced and 24 closed positions. Its largest new stake was Corteva: 722,792 shares worth $21.4M. The largest sale was Celgene Corp, an estimated $55.2M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- Luther King Capital Management (LKCM)'s largest Q2 2019 buy was Corteva: 722,792 shares worth $21.4M.
- Luther King Capital Management (LKCM) added most to Charles River Laboratories in Q2 2019, an estimated $29.9M increase.
- Luther King Capital Management (LKCM)'s biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $55.2M.
- Luther King Capital Management (LKCM) fully exited Anadarko Petroleum in Q2 2019, selling an estimated $6.31M.
- Luther King Capital Management (LKCM)'s ten largest holdings make up 24% of its $13.7B portfolio in Q2 2019.
- Luther King Capital Management (LKCM) opened 33 new positions and closed 24 in Q2 2019.
- Luther King Capital Management (LKCM)'s portfolio value rose 4.8% quarter-over-quarter to $13.7B.
Based on Luther King Capital Management (LKCM)'s 13F filing for Q2 2019, filed 12 Aug 2019.